313.67MMarket Cap-6269P/E (TTM)
5.970High5.620Low810.91KVolume5.820Open5.840Pre Close4.69MTurnover1.49%Turnover RatioLossP/E (Static)54.98MShares7.00052wk High4.47P/B310.53MFloat Cap2.57052wk Low--Dividend TTM54.43MShs Float52.000Historical High--Div YieldTTM5.99%Amplitude0.729Historical Low5.787Avg Price1Lot Size
CorMedix Stock Forum
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet